Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR1 | P21453 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | HTR1A | P08908 | 1/20 | 0.32 |
| ▸ | HTR7 | P34969 | 1/20 | 0.32 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.31 |
| ▸ | AR | P10275 | 1/20 | 0.31 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.31 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.30 |
| ▸ | MIF | P14174 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3606545 | 0.74 | KCNK3 (0.40) | KMT2AARMRGPRX4 | |
| SCHEMBL18833336 | 0.70 | RXRA (0.47) | MEN1KMT2AHTR1AHTR7AR | |
| SCHEMBL5414986 | 0.67 | MAPT (0.35) | MEN1KMT2A | |
| SCHEMBL10670908 | 0.64 | SLC22A12 (0.42) | — | |
| SCHEMBL8764071 | 0.63 | KCNK3 (0.44) | KMT2AARMRGPRX4 | |
| SCHEMBL15714461 | 0.62 | CYP2C9 (0.38) | S1PR1MEN1KMT2A | |
| SCHEMBL3290213 | 0.61 | SMN1; SMN2 (0.43) | MEN1KMT2A | |
| SCHEMBL6546900 | 0.61 | LMNA (0.41) | HTR1AHTR7 | |
| SCHEMBL29115260 | 0.61 | SLC22A12 (0.36) | MRGPRX4 | |
| SCHEMBL4394385 | 0.61 | SLC22A12 (0.36) | MEN1KMT2AHTR1AHTR7MRGPRX4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040157744-A1 | Substituted fluoroalkoxyphenylsulfonyl-amino(thio)carbonyltriazolino(thi)ones | BAYER CROPSCIENCE AG (DE) | 2004-08-12 | — | — | US | disclosed |
| EP-1379512-A1 | SUBSTITUTED FLUORALKOXYPHENYLSULFONYLAMINO(THIO)CARBONYLTRIAZOLINO(THI)ONES | Bayer CropScience AG (DE) | 2004-01-14 | — | — | EP | disclosed |
| WO-2002081458-A1 | SUBSTITUTED FLUORALKOXYPHENYLSULFONYLAMINO(THIO)CARBONYLTRIAZOLINO(THI)ONES | BAYER CROPSCIENCE AG (DE) | 2002-10-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040157744-A1 | Substituted fluoroalkoxyphenylsulfonyl-amino(thio)carbonyltriazolino(thi)ones | ROS1, RIF1, NAT1 | S1PR1 612/4885MEN1 2487/4885KMT2A 597/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.